| |
|
|
|
Antares Pharma Inc.  
|
|
4.625 0.185 (0.04%) |
11-20 16:00 |
|
Open: |
4.44 |
Pre close: |
4.44 |
Target:
|
5.53 
|
|
High: |
4.735 |
Low: |
4.44 |
Resistance:
|
4.74
5.53
|
|
Volume: |
3,436,609 |
Market Cap: |
755M |
Support:
|
3.80
3.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.32
|
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
3.78 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
3.40 |
Stochastic Oscillator |
%K(14,3):
|
94.15  |
|
MA(250): |
3.20 |
%D(3): |
93.69 |
|
Average Volume(K) |
3-Month: |
139508
|
52-Week |
High:
|
4.74 |
|
10-Days: |
394871 |
Low: |
2.53 |
|
RSI |
RSI(14):
|
85.29 |
Change(%): |
39.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.004 |
Return on Equity (ttm) |
-1.7 |
Shares Out. (M) |
163.23 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-6.5 |
Shares Float (M) |
150.58 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-1.03 |
% Held by Insiders |
7.34 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
92.0 |
% Held by Institutions |
42.29 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.199 |
Shares Short (K) |
4610 |
|
Book Value (p.s.) |
0.270 |
EBITDA (p.s.) |
-0.046 |
P/E |
-1156.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
17.13 |
|
Profit Margin |
-0.56 |
Operating Cash Flow
(M) |
-16.65 |
P/S |
7.11 |
|
Operating Margin |
-9.81 |
Levered Free Cash Flow
(M) |
-22.56 |
P/CF |
-45.34 |
|
|
|
|
|
|
